Skip to main content

Poseida Therapeutics, Inc.

PSTXDelisted Jan 8, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001661460

Poseida Therapeutics, Inc. was delisted on Jan 8, 2025; its insiders filed their last Form 4 on Jan 10, 2025; 116 institutions reported holding it in 13F filings for Q4 2024, worth $519.2M in total; no superinvestor held it.

Superinvestors holding PSTX, Q4 2024

See all superinvestors

No superinvestor reported holding PSTX in Q4 2024.